AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2022
Mar 8, 2022
35599_dirs_2022-03-08_7539823a-c231-48ac-b144-56e3a25aa98a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2022-03-08
Reporting Person: RALLIS CHRIS A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-03-08 | Common Shares | M | 8333 | $0.60 | Acquired | 11666 | Direct |
| 2022-03-08 | Common Shares | M | 9259 | $0.54 | Acquired | 20925 | Direct |
Footnotes
F1: Represents options granted on April 4, 2012, with a $0.60 USD strike price and an expiration of April 4, 2022.
F2: Represents options granted on May 17, 2012, with a $0.54 USD strike price and an expiration of May17, 2022.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20